Dopamine transporter binding in Gilles de la Tourette syndrome
- PMID: 10993492
- DOI: 10.1007/pl00007806
Dopamine transporter binding in Gilles de la Tourette syndrome
Abstract
Preliminary studies in patients with Gilles de la Tourette syndrome (TS) provided evidence of presynaptic dopaminergic dysfunction, demonstrating increased reuptake sites. Therefore we investigated striatal dopamine transporter binding in 12 TS patients and 9 control subjects using single photon emission computed tomography and 123I-labeled 2beta-carbomethoxy-3beta-(4-iodophenyl)tropane. In TS patients we found significantly higher relative striatal activity ratios (mean +/- SD 12.33 +/- 3.58) than in controls (9.36 +/- 1.35, P< 0.05). Only five patients, however, showed striatum/occipital cortex ratios more than 2 SD above the normal means. Seven patients had activity ratios within the average ratio of the control group plus 2 SD. Regarding the relationship between clinical parameters and striatum/occipital cortex ratios, we found an association between binding ratios and "self-injurious behavior" and "lack of impulse control." This study corroborates previous data suggesting an involvement of the dopaminergic system in TS pathology. Our results demonstrate that an increase in dopamine transporter capacity is a possible but not a necessary alteration, and which appears more likely when self-injurious behavior and lack of impulse control are associated.
Similar articles
-
Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease.J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):60-4. doi: 10.1136/jnnp.65.1.60. J Neurol Neurosurg Psychiatry. 1998. PMID: 9667562 Free PMC article.
-
Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis.Arch Neurol. 2000 Feb;57(2):205-8. doi: 10.1001/archneur.57.2.205. Arch Neurol. 2000. PMID: 10681078 Clinical Trial.
-
[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.Am J Psychiatry. 1995 Sep;152(9):1359-61. doi: 10.1176/ajp.152.9.1359. Am J Psychiatry. 1995. PMID: 7653693
-
[The dopamine transporter: characterization and physiopathologic implications].Encephale. 1995 Nov-Dec;21(6):445-51. Encephale. 1995. PMID: 8674469 Review. French.
-
Striatal dopaminergic alterations in Tourette's syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies.Transl Psychiatry. 2018 Aug 2;8(1):143. doi: 10.1038/s41398-018-0202-y. Transl Psychiatry. 2018. PMID: 30072700 Free PMC article.
Cited by
-
The management of tics.Mov Disord. 2009 Jan 15;24(1):15-24. doi: 10.1002/mds.22378. Mov Disord. 2009. PMID: 19170198 Free PMC article. Review.
-
Sexual dimorphism in histamine regulation of striatal dopamine.bioRxiv [Preprint]. 2025 Feb 28:2024.05.20.595049. doi: 10.1101/2024.05.20.595049. bioRxiv. 2025. Update in: J Neurosci. 2025 Jun 11;45(24):e2182242025. doi: 10.1523/JNEUROSCI.2182-24.2025. PMID: 38826392 Free PMC article. Updated. Preprint.
-
Sucking noise and collapse after central venous catheter removal.J R Soc Med. 2000 Nov;93(11):592-3. doi: 10.1177/014107680009301111. J R Soc Med. 2000. PMID: 11198693 Free PMC article. No abstract available.
-
Response inhibition and interference control in obsessive-compulsive spectrum disorders.Front Hum Neurosci. 2014 Jun 11;8:419. doi: 10.3389/fnhum.2014.00419. eCollection 2014. Front Hum Neurosci. 2014. PMID: 24966828 Free PMC article. Review.
-
Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate.J Neurol. 2002 Aug;249(8):1116-8. doi: 10.1007/s00415-002-0746-9. J Neurol. 2002. PMID: 12420715 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical